The FDA on Sept. 22 classified the recall of one lot of Vitruvias Therapeutics' 30 mg thyroid tablets as Class I, its highest risk level ...
A recalled thyroid medicine has been classified under the FDA's most serious risk level, indicating it could potentially be ...
A thyroid medication that was recalled last month because it’s potentially “superpotent" has been upgraded to the Food and ...
A thyroid medicine recall has received the FDA’s highest-risk classification after testing found one lot of Thyroid Tablets, ...
The FDA gave a Vitruvias Therapeutics thyroid tablet recall its highest risk classification. See which tablets are affected ...
The FDA upgraded a nationwide recall of Vitruvias Thyroid Tablets, USP 30 mg, to Class I after one lot was found potentially ...
Vitruvias advised patients taking tablets from the affected lot to contact their health care provider before stopping the ...
A thyroid medication recalled in August has been flagged with the highest risk warning by U.S. Food and Drug Administration.
Several weeks ago, Vitruvias Therapeutics said in a notice published by the FDA that it was voluntarily recalling one lot of thyroid tablets because the medication is “superpotent” and can “cause ...
WJW-TV Cleveland on MSN
Thyroid medication recall classified as FDA’s most urgent
A nationwide recall on thyroid tablets has now been classified as one the U.S. Food and Drug Administration's most serious and urgent recalls.
The US Food and Drug Administration has upgraded a recall of thyroid medication to its most serious classification after the manufacturer halted operations.Initially, Vitruvias Therapeutics announced ...
Vitruvias Therapeutics Inc. is voluntarily recalling nearly 2,000 bottles of Thyroid Tablets, USP, after the product was found to be superpotent, meaning the tablets contain more active ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results